• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常人肺支气管肺泡腔内促凝活性的调节。

Regulation of the procoagulant activity within the bronchoalveolar compartment of normal human lung.

作者信息

Chapman H A, Stahl M, Allen C L, Yee R, Fair D S

机构信息

Department of Medicine, University of Utah School of Medicine, Salt Lake City.

出版信息

Am Rev Respir Dis. 1988 Jun;137(6):1417-25. doi: 10.1164/ajrccm/137.6.1417.

DOI:10.1164/ajrccm/137.6.1417
PMID:3202380
Abstract

The nature of the procoagulant activity of normal bronchoalveolar fluid was examined both qualitatively and quantitatively. Unconcentrated, cell-free lavage freshly obtained from normal volunteers clotted normal plasma in a mean of 84 +/- 20 s. The procoagulant activity was initiated by Factor VII-tissue factor complexes as judged by differential activity in various plasmas genetically deficient in single clotting factors, by neutralization of the procoagulant activity with antibodies to either Factor VII or tissue factor, and by a Factor X activation assay. Preincubation of the lavage with calcium was required to demonstrate Factor VII activity in unconcentrated samples. The cell-free fluid contained about 8,500 thromboplastin units/mg protein, equivalent to a third of the thromboplastin standard and indicating high amounts of cofactor. Quantitation of Factor VII was estimated by functional analysis in coagulation and amidolytic assays with reference to dilutions of normal plasma of known Factor VII concentration. When lavage and diluted plasma were adjusted to yield equivalent amidolytic activities, the average ratio of the Factor VII-clotting activity of the alveolar fluid relative to plasma Factor VII was 19 +/- 7, suggesting the presence of Factor VIIa in lavage. In contrast to previous reports with serum or activated plasma, immunoblots of concentrated lavage revealed only single-chain Factor VII, and 125I-Factor VII added to the fluid was not converted to 125I-Factor VIIa, suggesting a unique control mechanism in the lung compartment which differs from plasma. When equivalent Factor VII amidolytic activities in diluted plasma and cell-free lavage were compared, the rates of Factor Xa formation were very similar.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

对正常支气管肺泡液促凝活性的性质进行了定性和定量研究。从正常志愿者新鲜获取的未浓缩、无细胞灌洗液使正常血浆平均在84±20秒内凝固。通过在单一凝血因子基因缺陷的各种血浆中的差异活性、用抗因子VII或组织因子的抗体中和促凝活性以及因子X激活试验判断,促凝活性由因子VII - 组织因子复合物启动。灌洗液与钙预温育是证明未浓缩样品中因子VII活性所必需的。无细胞液每毫克蛋白质含有约8500个凝血活酶单位,相当于凝血活酶标准的三分之一,表明辅因子含量高。通过凝血功能分析和酰胺水解试验并参照已知因子VII浓度的正常血浆稀释液来估计因子VII的定量。当灌洗液和稀释血浆调整至产生等效酰胺水解活性时,肺泡液中因子VII促凝活性相对于血浆因子VII的平均比值为19±7,提示灌洗液中存在因子VIIa。与先前关于血清或活化血浆的报道相反,浓缩灌洗液的免疫印迹仅显示单链因子VII,加入该液体中的125I - 因子VII未转化为125I - 因子VIIa,提示肺腔室中存在不同于血浆的独特控制机制。当比较稀释血浆和无细胞灌洗液中等效因子VII酰胺水解活性时,因子Xa形成速率非常相似。(摘要截短于250字)

相似文献

1
Regulation of the procoagulant activity within the bronchoalveolar compartment of normal human lung.正常人肺支气管肺泡腔内促凝活性的调节。
Am Rev Respir Dis. 1988 Jun;137(6):1417-25. doi: 10.1164/ajrccm/137.6.1417.
2
Fibrinopeptide A reactive peptides and procoagulant activity in bronchoalveolar lavage: relationship to rheumatoid interstitial lung disease.支气管肺泡灌洗中的纤维蛋白肽A反应性肽与促凝活性:与类风湿性间质性肺病的关系
J Rheumatol. 1989 May;16(5):592-8.
3
Procoagulant activity in bronchoalveolar lavage in the adult respiratory distress syndrome. Contribution of tissue factor associated with factor VII.成人呼吸窘迫综合征患者支气管肺泡灌洗中的促凝活性。与凝血因子VII相关的组织因子的作用。
Am Rev Respir Dis. 1987 Dec;136(6):1466-74. doi: 10.1164/ajrccm/136.6.1466.
4
Bronchoalveolar lavage procoagulant activity in bleomycin-induced lung injury in marmosets. Characterization and relationship to fibrin deposition and fibrosis.狨猴博来霉素诱导的肺损伤中支气管肺泡灌洗促凝活性。其特征及与纤维蛋白沉积和纤维化的关系。
Am Rev Respir Dis. 1987 Jul;136(1):124-33. doi: 10.1164/ajrccm/136.1.124.
5
Procoagulant (thromboplastin) activity in human bronchoalveolar lavage fluids is derived from alveolar macrophages.人支气管肺泡灌洗液中的促凝血剂(凝血活酶)活性源自肺泡巨噬细胞。
Eur Respir J. 1990 Jan;3(1):61-7.
6
Abnormalities in pathways of alveolar fibrin turnover among patients with interstitial lung disease.间质性肺疾病患者肺泡纤维蛋白周转途径的异常。
Am Rev Respir Dis. 1986 Mar;133(3):437-43. doi: 10.1164/arrd.1986.133.3.437.
7
Human alveolar macrophages synthesize factor VII in vitro. Possible role in interstitial lung disease.人肺泡巨噬细胞在体外合成凝血因子VII。在间质性肺疾病中的可能作用。
J Clin Invest. 1985 Jun;75(6):2030-7. doi: 10.1172/JCI111922.
8
Activation of human factor VII during clotting in vitro.
Blood. 1985 Jan;65(1):218-26.
9
Procoagulant activities in human alveolar macrophages.
Eur J Respir Dis. 1987 Nov;71(5):459-71.
10
Procoagulant and plasminogen activator activities of bronchoalveolar fluid in patients with pulmonary sarcoidosis.结节病患者支气管肺泡灌洗液的促凝和纤溶酶原激活物活性
Exp Lung Res. 1988;14(2):261-78. doi: 10.3109/01902148809115128.

引用本文的文献

1
Novel approach to exploring protease activity and targets in HIV-associated obstructive lung disease using combined proteomic-peptidomic analysis.采用联合蛋白质组学-肽组学分析方法探索 HIV 相关阻塞性肺疾病中蛋白酶活性和靶标的新方法。
Respir Res. 2024 Sep 10;25(1):337. doi: 10.1186/s12931-024-02933-9.
2
Novel Approach to Exploring Protease Activity and Targets in HIV-associated Obstructive Lung Disease using Combined Proteomic-Peptidomic Analysis.利用蛋白质组学-肽组学联合分析探索HIV相关阻塞性肺病中蛋白酶活性和靶点的新方法
Res Sq. 2024 Jun 4:rs.3.rs-4433194. doi: 10.21203/rs.3.rs-4433194/v1.
3
The Contribution of the Urokinase Plasminogen Activator and the Urokinase Receptor to Pleural and Parenchymal Lung Injury and Repair: A Narrative Review.
尿激酶型纤溶酶原激活物及其受体对胸膜和实质肺损伤与修复的作用:一个叙述性综述。
Int J Mol Sci. 2021 Feb 1;22(3):1437. doi: 10.3390/ijms22031437.
4
Nebulized anticoagulants in lung injury in critically ill patients-an updated systematic review of preclinical and clinical studies.危重症患者肺损伤中雾化抗凝剂——临床前和临床研究的最新系统评价
Ann Transl Med. 2017 Nov;5(22):444. doi: 10.21037/atm.2017.08.23.
5
Dexamethasone inhibits endotoxin-induced coagulopathy in human lungs.地塞米松可抑制人肺脏内毒素诱导的凝血病。
J Thromb Haemost. 2016 Dec;14(12):2471-2477. doi: 10.1111/jth.13504. Epub 2016 Oct 24.
6
Regulation of alveolar procoagulant activity and permeability in direct acute lung injury by lung epithelial tissue factor.肺上皮组织因子对直接急性肺损伤中肺泡促凝活性和通透性的调节作用
Am J Respir Cell Mol Biol. 2015 Nov;53(5):719-27. doi: 10.1165/rcmb.2014-0179OC.
7
Complement 3 is involved with ventilator-induced lung injury.补体 3 与呼吸机相关性肺损伤有关。
Int Immunopharmacol. 2011 Dec;11(12):2138-43. doi: 10.1016/j.intimp.2011.09.008. Epub 2011 Oct 5.
8
Disorders of lung matrix remodeling.肺基质重塑障碍
J Clin Invest. 2004 Jan;113(2):148-57. doi: 10.1172/JCI20729.
9
Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse.博来霉素诱导的小鼠肺损伤过程中促凝血和纤溶基因表达的变化。
J Clin Invest. 1995 Sep;96(3):1621-30. doi: 10.1172/JCI118201.
10
Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome.凝血和纤维蛋白溶解途径的局部异常易导致成人呼吸窘迫综合征中的肺泡纤维蛋白沉积。
J Clin Invest. 1989 Aug;84(2):695-705. doi: 10.1172/JCI114217.